Altered proinflammatory cytokine production and enhanced resistance to trypanosoma congolense infection in lymphotoxin β-deficient mice

Journal of Infectious Diseases

Volumn 200, Issue 3, 2009, Pages 361-369

  Okwor, Ifeoma ^a   Muleme, Helen ^a   Jia, Ping ^a   Uzonna, Jude E ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G2A; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR ANTIBODY; INTERLEUKIN 12; INTERLEUKIN 6; LYMPHOTOXIN BETA; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CYTOKINE PRODUCTION; FEMALE; INFECTION RESISTANCE; MOUSE; NAGANA; NONHUMAN; PARASITEMIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGULATORY T LYMPHOCYTE; SURVIVAL TIME; T CELL DEPLETION; TRYPANOSOMA CONGOLENSE; WILD TYPE;

ANIMALS; CYTOKINES; FEMALE; GENE DELETION; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; LYMPHOTOXIN-BETA; MICE; MICE, INBRED C57BL; PARASITEMIA; SIGNAL TRANSDUCTION; SPECIFIC PATHOGEN-FREE ORGANISMS; TRYPANOSOMA CONGOLENSE; TRYPANOSOMIASIS, AFRICAN;

EID: 67650667814     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/599792     Document Type: Article

References (41)

1. African Development Bank Group. Sleeping sickness. Available at: http://www.dfid-ahp.org.uk/index.php?section = 3&subsection = 24. Accessed 10 June 2009.
2. Hertz CJ, Filutowicz H, Mansfield JM. Resistance to the African trypanosomes is IFN-gamma dependent. J Immunol 1998; 161:6775-83.
3. Schopf LR, Filutowicz H, Bi XJ, Mansfield JM. Interleukin-4-dependent immunoglobulin G1 isotype switch in the presence of a polarized antigen-specific Thl-cell response to the trypanosome variant surface glycoprotein. Infect Immun 1998; 66:451-61.
4. Magez S, Radwanska M, Drennan M, et al. Interferon-gamma and nitric oxide in combination with antibodies are key protective host immune factors during Trypanosoma congolense Tc13 Infections. J Infect Dis 2006; 193:1575-83.
5. Shi M, Pan W, Tabel H. Experimental African trypanosomiasis: IFNgamma mediates early mortality. Eur J Immunol 2003; 33:108-18.
6. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001; 104:487-501.
7. Benedict CA, Banks TA, Ware CF. Death and survival: viral regulation of TNF signaling pathways. Curr Opin Immunol 2003; 15:59-65.
8. Ware CF. Network communications: lymphotoxins, LIGHT, and TNF. Annu Rev Immunol 2005; 23:787-819.
9. Liew FY, Li Y, Millott S. Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide. J Immunol 1990; 145:4306-10.
10. Liew FY, Li Y, Millott S. Tumour necrosis factor (TNF-alpha) in leishmaniasis. II. TNF-alpha-induced macrophage leishmanicidal activity is mediated by nitric oxide from L-arginine. Immunology 1990; 71:556-9.
11. Kanaly ST, Nashleanas M, Hondowicz B, Scott P. TNF receptor p55 is required for elimination of inflammatory cells following control of intracellular pathogens. J Immunol 1999; 163:3883-9.
12. Magez S, Radwanska M, Beschin A, Sekikawa K, De Baetselier P. Tumor necrosis factor alpha is a key mediator in the regulation of experimental Trypanosoma brucei infections. Infect Immun 1999; 67:3128-32.
13. Magez S, Stijlemans B, Caljon G, Eugster HP, De Baetselier P. Control of experimental Trypanosoma brucei infections occurs independently of lymphotoxin-alpha induction. Infect Immun 2002; 70:1342-51.
14. Iraqi F, Sekikawa K, Rowlands J, Teale A. Susceptibility of tumour necrosis factor-alpha genetically deficient mice to Trypanosoma congolense infection. Parasite Immunol 2001; 23:445-51.
15. Naessens J, Kitani H, Momotani E, Sekikawa K, Nthale JM, Iraqi F. Susceptibility of TNF-alpha-deficient mice to Trypanosoma congolense is not due to a defective antibody response. Acta Trop 2004; 92:193-203.
16. Gavrieli M, Sedy J, Nelson CA, Murphy KM. BTLA and HVEM cross talk regulates inhibition and costimulation. Adv Immunol 2006; 92: 157-85.
17. Murphy KM, Nelson CA, Sedy JR. Balancing co-stimulation and inhibition with BTLA and HVEM. Nat Rev Immunol 2006; 6:671-81.
18. Wilhelm P, Riminton DS, Ritter U, et al. Membrane lymphotoxin contributes to anti-leishmanial immunity by controlling structural integrity of lymphoid organs. Eur J Immunol 2002; 32:1993-2003.
19. Tumanov AV, Kuprash DV, Nedospasov SA. The role of lymphotoxin in development and maintenance of secondary lymphoid tissues. Cytokine Growth Factor Rev 2003; 14:275-88.
20. Xu G, Liu D, Fan Y, et al. Lymphotoxin alpha beta 2 (membrane lymphotoxin) is critically important for resistance to Leishmania major infection in mice. J Immunol 2007; 179:5358-66.
21. Ngo VN, Korner H, Gunn MD, et al. Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J Exp Med 1999; 189: 403-12.
22. Tabel H. Activation of the alternative pathway of bovine complement by Trypanosoma congolense. Parasite Immunol 1982; 4:329-35.
23. Lanham SM, Godfrey DG. Isolation of salivarian trypanosomes from man and other mammals using DEAE-cellulose. Exp Parasitol 1970; 28:521-34.
24. Wei G, Tabel H. Regulatory T cells prevent control of experimental African trypanosomiasis. J Immunol 2008; 180:2514-21.
25. Uzonna JE, Kaushik RS, Gordon JR, Tabel H. Cytokines and antibody responses during Trypanosoma congolense infections in two inbred mouse strains that differ in resistance. Parasite Immunol 1999; 21: 57-71.
26. Namangala B, Noel W, De Baetselier P, Brys L, Beschin A. Relative contribution of interferon-gamma and interleukin-10 to resistance to murine African trypanosomosis. J Infect Dis 2001; 183:1794-800.
27. Bosschaerts T, Guilliams M, Noel W, et al. Alternatively activated myeloid cells limit pathogenicity associated with African trypanosomiasis through the IL-10 inducible gene selenoprotein P. J Immunol 2008; 180:6168-75.
28. McDevitt H, Munson S, Ettinger R, Wu A. Multiple roles for tumor necrosis factor-alpha and lymphotoxin alpha/beta in immunity and autoimmunity. Arthritis Res 2002; 4(Suppl 3):S141-52.
29. Wu AJ, Hua H, Munson SH, McDevitt HO. Tumor necrosis factoralpha regulation of CD4+CD25+ T cell levels in NOD mice. Proc Natl Acad Sci U S A 2002; 99:12287-92.
30. Guilliams M, Oldenhove G, Noel W, et al. African trypanosomiasis: naturally occurring regulatory T cells favor trypanotolerance by limiting pathology associated with sustained type 1 inflammation. J Immunol 2007; 179:2748-57.
31. Tabel H, Kaushik RS, Uzonna JE. Susceptibility and resistance to Trypanosoma congolense infections. Microbes Infect 2000; 2:1619-29.
32. Tabel H, Wei G, Shi M. T cells and immunopathogenesis of experimental African trypanosomiasis. Immunol Rev 2008; 225:128-39.
33. Guilliams M, Bosschaerts T, Herin M, et al. Experimental expansion of the regulatory T cell population increases resistance to African trypanosomiasis. J Infect Dis 2008; 198:781-91.
34. Kitani H, Black SJ, Nakamura Y, et al. Recombinant tumor necrosis factor alpha does not inhibit the growth of African trypanosomes in axenic cultures. Infect Immun 2002; 70:2210-4.
35. Shi M, Wei G, Pan W, Tabel H. Experimental African trypanosomiasis: a subset of pathogenic, IFN-gamma-producing, MHC class II-restricted CD4+ T cells mediates early mortality in highly susceptible mice. J Immunol 2006; 176:1724-32.
36. Shi MQ, Wei GJ, Tabel H. Trypanosoma congolense infections: MHC class II-restricted immune responses mediate either protection or disease, depending on IL-10 function. Parasite Immunol 2007; 29:107-11.
37. Lucas R, Magez S, De Leys R, et al. Mapping the lectin-like activity of tumor necrosis factor. Science 1994; 263:814-7.
38. Magez S, Geuskens M, Beschin A, et al. Specific uptake of tumor necrosis factor-alpha is involved in growth control of Trypanosoma brucei. J Cell Biol 1997; 137:715-27.
39. Reiner SL, Locksley RM. The regulation of immunity to Leishmania major. Annu Rev Immunol 1995; 13:151-77.
40. Koni PA, Sacca R, Lawton P, Browning JL, Ruddle NH, Flavell RA. Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice. Immunity 1997; 6: 491-500.
41. Tumanov AV, Grivennikov SI, Shakhov AN, et al. Dissecting the role of lymphotoxin in lymphoid organs by conditional targeting. Immunol Rev 2003; 195:106-16.